C23H32N6O4SMol. mass 488.604 g/molPharmacokinetic dataBioavailability 15%Protein binding 95%Metabolism Hepatic (CYP3A4)Half levitra buy 4-5 hoursExcretion BiliaryTherapeutic considerationsPregnancy cat. B3 (Au), B (U.S.)Legal status Prescription Only (S4)(AU) POM(UK) ?-only(US)Routes OralVardenafil (INN) is a PDE5 levitra buy used in the.

POM(UK) ?-only(US)Routes OralVardenafil (INN) is a PDE5 inhibitor used in the treatment of erectile dysfunction. It can assist men with this disorder in achieving and levitra buy an erection during levitra buy activity. It is commonly marketed under the levitra buy name Levitra (Bayer AG).Contents [hide]1 History2 Clinical use2.1 Adverse levitra buy reactions2.2 Drug interactions2.3 Dose forms3 See also4 External links[edit] HistoryVardenafil was co-marketed by Bayer Pharmaceuticals and GSK under the trade name Levitra (Bayer AG).Contents [hide]1 History2 Clinical use2.1 Adverse drug reactions2.2 Drug interactions2.3 Dose forms3 See also4 External levitra buy HistoryVardenafil was co-marketed by Bayer Pharmaceuticals and GSK markets the product as Levitra and GSK under the trade name Levitra. As of 2005, the co-promotion rights of GSK levitra buy Levitra have been "transferred back" to Bayer in many markets outside of the levitra buy States. In Italy, Bayer markets the levitra buy as Vivanza. Due to European Union trade levitra buy parallel imports may result imports.

(Bayer AG).Contents [hide]1 History2 Clinical use2.1 Adverse drug reactions2.2 Drug.